In one such experiment, the CD44 splice isomer (CD44v6) was used to separate the CD44v6+ epithelial membrane antigen negative (EMA-) stem cell subtype from bladder tumors [33]. The gene discussed is MUC1; the disease is urinary bladder neoplasm.